Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
07 2023
Historique:
medline: 19 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

Prior studies associating acute kidney injury (AKI) with more rapid subsequent loss of kidney function had methodological limitations, including inadequate control for differences between patients who had AKI and those who did not. To determine whether AKI is independently associated with subsequent kidney function trajectory among patients with chronic kidney disease (CKD). Multicenter prospective cohort study. United States. Patients with CKD ( Hospitalized AKI was defined by a 50% or greater increase in inpatient serum creatinine (SCr) level from nadir to peak. Kidney function trajectory was assessed using estimated glomerular filtration rate (eGFR) based on SCr level (eGFRcr) or cystatin C level (eGFRcys) measured at annual study visits. During a median follow-up of 3.9 years, 433 participants had at least 1 AKI episode. Most episodes (92%) had stage 1 or 2 severity. There were decreases in eGFRcr (-2.30 [95% CI, -3.70 to -0.86] mL/min/1.73 m Few cases of severe AKI, no adjudication of AKI cause, and lack of information about nephrotoxic exposures after hospital discharge. After pre-AKI eGFR, proteinuria, and other covariables were accounted for, the association between mild to moderate AKI and worsening subsequent kidney function in patients with CKD was small. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

Sections du résumé

BACKGROUND
Prior studies associating acute kidney injury (AKI) with more rapid subsequent loss of kidney function had methodological limitations, including inadequate control for differences between patients who had AKI and those who did not.
OBJECTIVE
To determine whether AKI is independently associated with subsequent kidney function trajectory among patients with chronic kidney disease (CKD).
DESIGN
Multicenter prospective cohort study.
SETTING
United States.
PARTICIPANTS
Patients with CKD (
MEASUREMENTS
Hospitalized AKI was defined by a 50% or greater increase in inpatient serum creatinine (SCr) level from nadir to peak. Kidney function trajectory was assessed using estimated glomerular filtration rate (eGFR) based on SCr level (eGFRcr) or cystatin C level (eGFRcys) measured at annual study visits.
RESULTS
During a median follow-up of 3.9 years, 433 participants had at least 1 AKI episode. Most episodes (92%) had stage 1 or 2 severity. There were decreases in eGFRcr (-2.30 [95% CI, -3.70 to -0.86] mL/min/1.73 m
LIMITATIONS
Few cases of severe AKI, no adjudication of AKI cause, and lack of information about nephrotoxic exposures after hospital discharge.
CONCLUSION
After pre-AKI eGFR, proteinuria, and other covariables were accounted for, the association between mild to moderate AKI and worsening subsequent kidney function in patients with CKD was small.
PRIMARY FUNDING SOURCE
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

Identifiants

pubmed: 37429030
doi: 10.7326/M22-3617
doi:

Substances chimiques

Cystatin C 0
Creatinine AYI8EX34EU

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

961-968

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK060990
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060984
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061022
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061021
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061028
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060980
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060963
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060902
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK060990
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR029879
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109036
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024131
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK119199
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK119562
Pays : United States

Investigateurs

Harold I Feldman (HI)
Robert G Nelson (RG)
Mahboob Rahman (M)
Vallabh O Shah (VO)

Auteurs

Anthony N Muiru (AN)

Division of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).

Jesse Y Hsu (JY)

Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (J.Y.H., X.Z.).

Xiaoming Zhang (X)

Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (J.Y.H., X.Z.).

Lawrence J Appel (LJ)

Division of General Internal Medicine, Johns Hopkins University, Baltimore, Maryland (L.J.A.).

Jing Chen (J)

Section of Nephrology & Hypertension, Tulane University School of Medicine, New Orleans, Louisiana (J.C.).

Debbie L Cohen (DL)

Division of Nephrology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (D.L.C.).

Paul E Drawz (PE)

Division of Nephrology and Hypertension, University of Minnesota Medical School, Minneapolis, Minnesota (P.E.D.).

Barry I Freedman (BI)

Section on Nephrology, Wake Forest University, Winston-Salem, North Carolina (B.I.F.).

Alan S Go (AS)

Division of Research, Kaiser Permanente Northern California, Oakland, California (A.S.G.).

Jiang He (J)

Tulane University School of Public Health & Tropical Medicine, New Orleans, Louisiana (J.H.).

Edward J Horwitz (EJ)

Case Western Reserve University School of Medicine, Cleveland, Ohio (E.J.H.).

Raymond K Hsu (RK)

Division of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).

James P Lash (JP)

Division of Nephrology, University of Illinois Health, Chicago, Illinois (J.P.L., A.P., A.C.R.).

Kathleen D Liu (KD)

Division of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).

Ian E McCoy (IE)

Division of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).

Anna Porter (A)

Division of Nephrology, University of Illinois Health, Chicago, Illinois (J.P.L., A.P., A.C.R.).

Panduranga Rao (P)

Division of Nephrology, University of Michigan Health, Ann Arbor, Michigan (P.R.).

Ana C Ricardo (AC)

Division of Nephrology, University of Illinois Health, Chicago, Illinois (J.P.L., A.P., A.C.R.).

Hernan Rincon-Choles (H)

Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio (H.R., J.T.).

James Sondheimer (J)

Division of Nephrology and Hypertension, Wayne State University School of Medicine, Detroit, Michigan (J.S.).

Jonathan Taliercio (J)

Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio (H.R., J.T.).

Mark Unruh (M)

University of New Mexico Health Sciences, Albuquerque, New Mexico (M.U.).

Chi-Yuan Hsu (CY)

Division of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California, and Division of Research, Kaiser Permanente Northern California, Oakland, California (C.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH